A conspicuous reduced plasma creatinine: the first presenting sign of Waldenstrom macroglobulinemia

Articles in the same Issue

1. Frontmatter
2. Editorials
3. EU health policy is on the brink of a spectacular own-goal that will harm patients and hamper innovation
4. Theranos revisited: the trial and lessons learned
5. Reviews
6. Review and evolution of guidelines for diagnosis of COVID-19 vaccine induced thrombotic thrombocytopenia (VITT)
7. High-sensitivity cardiac troponins in pediatric population
8. Opinion Papers
9. Implementation of the new EU IVD regulation – urgent initiatives are needed to avert impending crisis
10. Exploration of novel biomarkers for hypertensive disorders of pregnancy by comprehensive analysis of peptide fragments in blood: their potential and technologies supporting quantification
11. General Clinical Chemistry and Laboratory Medicine
12. Total lab automation: sample stability of clinical chemistry parameters in an automated storage and retrieval module
13. Instability of corticotropin during long-term storage – myth or reality?
14. External quality assessment of serum indices: Spanish SEQC-ML program
15. Comparison of two LC-MS/MS methods for the quantification of 24,25-dihydroxyvitamin D3 in patients and external quality assurance samples
16. Isotope dilution LC-MS/MS quantification of the cystic fibrosis transmembrane conductance regulator (CFTR) modulators ivacaftor, lumacaftor, tezacaftor, elexacaftor, and their major metabolites in human serum
17. Hematology and Coagulation
18. The development of autoverification system of lymphocyte subset assays on the flow cytometry platform
19. Cancer Diagnostics
20. Comparison of the QuikRead go^® point-of-care faecal immunochemical test for haemoglobin with the FOB Gold Wide^® laboratory analyser to diagnose colorectal cancer in symptomatic patients
21. Evaluation of circulating Dickkopf-1 as a prognostic biomarker in ovarian cancer patients
22. Cardiovascular Diseases
23. Soluble CD40 ligand and outcome in patients with coronary artery disease undergoing percutaneous coronary intervention
24. Diabetes
25. Lot variation and inter-device differences contribute to poor analytical performance of the DCA Vantage™ HbA_1c POCT instrument in a true clinical setting
26. Infectious Diseases
27. Lipase elevation in serum of COVID-19 patients: frequency, extent of increase and clinical value
28. Acknowledgment
29. Acknowledgment
30. Letters to the Editors
31. Presepsin value predicts the risk of developing severe/critical COVID-19 illness: results of a pooled analysis
32. Measuring accuracy of the neutralizing activity of COVID-19 convalescent plasma
33. Evaluation of reference intervals for classical and alternative pathway functional complement assays
34. Reference values for plasma neurofilament light chain in healthy Chinese children
35. Cerebrospinal fluid neurogranin in Alzheimer’s disease studies: are immunoassay results interchangeable?
36. Pepsin pretreatment corrects underestimation of 25-hydroxyvitamin D measurement by an automated immunoassay in subjects with high vitamin D binding protein levels
37. A conspicuous reduced plasma creatinine: the first presenting sign of Waldenstrom macroglobulinemia
38. Effect of non-linearity on rheumatoid factor assay in Beckman system IMMAGE800